Licai He

1.1k total citations
21 papers, 538 citations indexed

About

Licai He is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Licai He has authored 21 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Licai He's work include Glycosylation and Glycoproteins Research (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and RNA modifications and cancer (3 papers). Licai He is often cited by papers focused on Glycosylation and Glycoproteins Research (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and RNA modifications and cancer (3 papers). Licai He collaborates with scholars based in China and United States. Licai He's co-authors include Haihua Gu, Hongzhi Li, Jiawei Cao, Guang Wu, Guoqiang Chen, Shenmeng Gao, Yingli Wu, Chuanxu Liu, Jian‐Xin Pu and Mingxuan Wu and has published in prestigious journals such as Oncogene, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Licai He

21 papers receiving 537 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Licai He China 12 357 127 118 99 52 21 538
Ze-Yan Zhang China 13 444 1.2× 158 1.2× 86 0.7× 60 0.6× 48 0.9× 33 618
Philippe Depeille United States 13 437 1.2× 162 1.3× 73 0.6× 108 1.1× 44 0.8× 15 616
Jacqueline Sayyah United States 9 368 1.0× 178 1.4× 78 0.7× 43 0.4× 47 0.9× 11 534
Z. Peter Wang China 14 390 1.1× 121 1.0× 128 1.1× 31 0.3× 56 1.1× 18 524
Shuyun Rao United States 13 526 1.5× 157 1.2× 124 1.1× 65 0.7× 79 1.5× 24 722
Rongfu Tu China 11 533 1.5× 132 1.0× 228 1.9× 62 0.6× 53 1.0× 22 652
Sonia Mohinta United States 9 361 1.0× 167 1.3× 153 1.3× 118 1.2× 43 0.8× 10 594
Siao Muk Cheng Taiwan 12 415 1.2× 136 1.1× 110 0.9× 62 0.6× 59 1.1× 26 598
Isabel Soto‐Cruz Mexico 15 205 0.6× 208 1.6× 126 1.1× 203 2.1× 41 0.8× 31 574
Minhong Tang Ireland 9 339 0.9× 256 2.0× 74 0.6× 84 0.8× 58 1.1× 14 563

Countries citing papers authored by Licai He

Since Specialization
Citations

This map shows the geographic impact of Licai He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Licai He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Licai He more than expected).

Fields of papers citing papers by Licai He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Licai He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Licai He. The network helps show where Licai He may publish in the future.

Co-authorship network of co-authors of Licai He

This figure shows the co-authorship network connecting the top 25 collaborators of Licai He. A scholar is included among the top collaborators of Licai He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Licai He. Licai He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cao, Jiawei, Tong Zhou, Tom Wu, et al.. (2025). Targeting estrogen-regulated system xc− promotes ferroptosis and endocrine sensitivity of ER+ breast cancer. Cell Death and Disease. 16(1). 30–30. 8 indexed citations
2.
Cao, Jiawei, Tao Wu, Tong Zhou, et al.. (2025). USP35 promotes the growth of ER positive breast cancer by inhibiting ferroptosis via BRD4-SLC7A11 axis. Communications Biology. 8(1). 64–64. 2 indexed citations
3.
Li, Lan, Jiawei Cao, Chunyan Chen, et al.. (2023). Antitumor effect of a novel humanized MUC1 antibody-drug conjugate on triple-negative breast cancer. Heliyon. 9(4). e15164–e15164. 3 indexed citations
4.
Wang, Yang, Lan Chen, Zhuo Chen, et al.. (2023). PRRG4 regulates mitochondrial function and promotes migratory behaviors of breast cancer cells through the Src-STAT3-POLG axis. Cancer Cell International. 23(1). 323–323. 2 indexed citations
5.
Wu, Guang, Lan Li, Mengnan Liu, et al.. (2022). Therapeutic effect of a MUC1-specific monoclonal antibody-drug conjugates against pancreatic cancer model. Cancer Cell International. 22(1). 417–417. 8 indexed citations
6.
Wu, Guang, Lan Li, Wei Sun, et al.. (2021). A novel humanized MUC1 antibody–drug conjugate for the treatment of trastuzumab-resistant breast cancer. Acta Biochimica et Biophysica Sinica. 53(12). 1625–1639. 12 indexed citations
7.
Cao, Jiawei, Guang Wu, Yaqi Wang, et al.. (2021). USP35, regulated by estrogen and AKT, promotes breast tumorigenesis by stabilizing and enhancing transcriptional activity of estrogen receptor α. Cell Death and Disease. 12(6). 619–619. 21 indexed citations
8.
Li, Zunling, Mi Deng, Fangfang Huang, et al.. (2020). Correction to: LILRB4 ITIMs mediate the T cell suppression and infiltration of acute myeloid leukemia cells. Cellular and Molecular Immunology. 17(3). 302–304. 2 indexed citations
9.
Zhang, Lingling, Guang Wu, Jiawei Cao, et al.. (2020). PRRG4 promotes breast cancer metastasis through the recruitment of NEDD4 and downregulation of Robo1. Oncogene. 39(49). 7196–7208. 25 indexed citations
10.
Ma, Lan, Haoying Li, Lu Ge, et al.. (2020). Primaquine phosphate induces the apoptosis of ATRA-resistant acute promyelocytic leukemia cells by inhibition of the NF-κB pathway. Journal of Leukocyte Biology. 107(4). 685–693. 1 indexed citations
11.
Qiu, Ting, Jiawei Cao, Yaqi Wang, et al.. (2020). 24‐Dehydrocholesterol reductase promotes the growth of breast cancer stem‐like cells through the Hedgehog pathway. Cancer Science. 111(10). 3653–3664. 25 indexed citations
12.
Li, Tong, Min Liu, Guang Wu, et al.. (2019). Gab2 promotes cancer stem cell like properties and metastatic growth of ovarian cancer via downregulation of miR-200c. Experimental Cell Research. 382(1). 111462–111462. 25 indexed citations
13.
Li, Zunling, Mi Deng, Fangfang Huang, et al.. (2019). LILRB4 ITIMs mediate the T cell suppression and infiltration of acute myeloid leukemia cells. Cellular and Molecular Immunology. 17(3). 272–282. 58 indexed citations
14.
Bi, Laixi, Bin Zhou, Haiying Li, et al.. (2018). A novel miR-375-HOXB3-CDCA3/DNMT3B regulatory circuitry contributes to leukemogenesis in acute myeloid leukemia. BMC Cancer. 18(1). 182–182. 53 indexed citations
15.
He, Licai, He Huang, Rui Gong, et al.. (2018). Mebendazole exhibits potent anti-leukemia activity on acute myeloid leukemia. Experimental Cell Research. 369(1). 61–68. 17 indexed citations
16.
Ma, Hua, et al.. (2017). Shp1 positively regulates EGFR signaling by controlling EGFR protein expression in mammary epithelial cells. Biochemical and Biophysical Research Communications. 488(3). 439–444. 3 indexed citations
17.
He, Licai, Hua Ma, Zhenfeng Zhu, et al.. (2017). Targeting Androgen Receptor in Treating HER2 Positive Breast Cancer. Scientific Reports. 7(1). 14584–14584. 50 indexed citations
18.
Li, Haiying, Chiqi Chen, Lihui Yin, et al.. (2014). Honokiol Induces Cell Cycle Arrest and Apoptosis Via Inhibiting Class I Histone Deacetylases in Acute Myeloid Leukemia. Journal of Cellular Biochemistry. 116(2). 287–298. 16 indexed citations
19.
Liu, Chuanxu, Qianqian Yin, Huchen Zhou, et al.. (2012). Adenanthin targets peroxiredoxin I and II to induce differentiation of leukemic cells. Nature Chemical Biology. 8(5). 486–493. 180 indexed citations
20.
He, Licai, Hanzhang Xu, Zhimin Gu, et al.. (2011). Ikaros is degraded by proteasome-dependent mechanism in the early phase of apoptosis induction. Biochemical and Biophysical Research Communications. 406(3). 430–434. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ze-Yan Zhang Breakdown of academic impact, for papers by Philippe Depeille Breakdown of academic impact, for papers by Jacqueline Sayyah Breakdown of academic impact, for papers by Z. Peter Wang Breakdown of academic impact, for papers by Shuyun Rao Breakdown of academic impact, for papers by Rongfu Tu Breakdown of academic impact, for papers by Sonia Mohinta Breakdown of academic impact, for papers by Siao Muk Cheng Breakdown of academic impact, for papers by Isabel Soto‐Cruz Breakdown of academic impact, for papers by Minhong Tang
Rankless by CCL
2026